Decreased serum endoglin level in patients with amyotrophic lateral sclerosis: a preliminary report

References

• Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653–60
   PubMed Web of Science ®Google Scholar
• Sanchez‐Elsner T., Botella L. M., Velasco B., Langa C., Bernabeu C. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor‐β pathways. J Biol Chem 2002; 277: 43799–808
   PubMed Web of Science ®Google Scholar
• Bellon T., Corbi A., Lastres P., Cales C., Cebrian M., Vera S., et al. Identification and expression of two forms of the human transforming growth factor‐β‐binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol 1993; 23: 2340–5
   PubMed Web of Science ®Google Scholar
• Duff S. E., Li C., Garland J. M., Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J 2003; 17: 984–92
   PubMed Web of Science ®Google Scholar
• Wong S. H., Hamel L., Chevalier S., Philip A. Endoglin expression on human microvascular endothelial cells association with βglycan and formation of higher order complexes with TGF‐β signalling receptors. Eur J Biochem 2000; 267: 5550–60
   PubMedGoogle Scholar
• Lebrin F., Goumans M. J., Jonker L., Carvalho R. L., Valdimarsdottir G., Thorikay M., et al. Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction. EMBO J 2004; 23: 4018–28
   PubMed Web of Science ®Google Scholar
• Tesseur I., Wyss‐Coray T. A role for TGF‐β signaling in neurodegeneration: evidence from genetically engineered models. Curr Alzh Res 2006; 3: 505–13
   PubMedGoogle Scholar
• Lastres P., Letamendia A., Zhang H., Rius C., Almendro M., Raab U., et al. Endoglin modulates cellular responses to TGF‐β1. J Cell Biol 1996; 133: 1109–21
   PubMed Web of Science ®Google Scholar
• Brooks B. R. El Escorial Word Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124 Suppl: 96–107
   PubMed Web of Science ®Google Scholar
• Gordon P. H., Miller R. G., Moore D. H. ALSFRS‐R. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5: 90–3
   PubMed Web of Science ®Google Scholar
• Lambrechts D., Storkebaum E., Morimoto M., Del‐Favero J., Desmet F., Marklund S. L., et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003; 34: 383–94
   PubMed Web of Science ®Google Scholar
• Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., et al. Deletion of the hypoxia‐response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28: 131–8
   PubMed Web of Science ®Google Scholar
• Greenberg D. A., Jin K. From angiogenesis to neuropathology. Nature 2005; 438: 954–9
   PubMed Web of Science ®Google Scholar
• Azzouz M., Ralph G. S., Storkebaum E., Walmsley L. E., Mitrophanous K. A., Kinqsman S. M., et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004; 429: 413–7
   PubMed Web of Science ®Google Scholar
• Zheng C., Nennesmo I., Fadeel B., Henter J. I. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2004; 56: 564–7
   PubMed Web of Science ®Google Scholar
• Lambrechts D., Lafuste P., Carmeliet P., Conway E. M. Another angiogenic gene linked to amyotrophic lateral sclerosis. Trends Mol Med 2006; 12: 345–7
   PubMed Web of Science ®Google Scholar
• Greenway M. J., Alexander M. D., Ennis S., Traynor B. J., Corr B., Frost E., et al. A novel candidate region for ALS on chromosome 14q11.2. Neurology 2004; 63: 1936–8
   PubMed Web of Science ®Google Scholar
• Nygren I., Larsson A., Johansson A., Askmark H. VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis. Neuroreport 2002; 13: 2199–201
   PubMed Web of Science ®Google Scholar
• Cronin S., Greenway M. J., Ennis S., Kieran D., Green A., Prehn J. H., et al. Elevated serum angiogenin levels in ALS. Neurology 2006; 67: 1833–6
   PubMed Web of Science ®Google Scholar
• Li D. Y., Sorensen L. K., Brooke B. S., Urness L. D., Davis E. C., Taylor D. G., et al. Defective angiogenesis in mice lacking endoglin. Science 1999; 284: 1534–7
   PubMed Web of Science ®Google Scholar
• van Laake L. W., van den Driesche S., Post S., Feijen A., Jansen M. A., Driessens H. M., et al. Endoglin has a crucial role in blood cell‐mediated vascular repair. Circulation 2006; 114: 2288–97
   PubMed Web of Science ®Google Scholar
• Dziewulska D., Rafalowska J. Role of endoglin and transforming growth factor‐β in progressive white matter damage after an ischemic stroke. Neuropathology 2006; 26: 298–306
   PubMed Web of Science ®Google Scholar
• Xu B., Wu Y. Q., Huey M., Arthur H. M., Marchuk D. A., Hashimoto T., et al. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab 2004; 24: 237–44
   PubMed Web of Science ®Google Scholar
• Carvalho R. L., Jonker L., Goumans M. J., Larsson J., Bouwman P., Karlsson S., et al. Defective paracrine signaling by TGFβ in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 2004; 131: 6237–47
   PubMed Web of Science ®Google Scholar
• Zhu Y., Sun Y., Xie L., Jin K., Sheibani N., Greenberg D. A. Hypoxic induction of endoglin via mitogen‐activated protein kinases in mouse brain microvascular endothelial cells. Stroke 2003; 34: 2483–8
   PubMed Web of Science ®Google Scholar
• Jerkic M., Rodriquez‐Barbero A., Prieto M., Toporsian M., Pericacho M., Rivas‐Elena J. V., et al. Reduced angiogenic responses in adult endoglin heterozygous mice. Cardiovasc Res 2006; 69: 845–54
   PubMed Web of Science ®Google Scholar
• Tesseur I., Zou K., Esposito L., Bard F., Berber E., van Can J., et al. Deficiency in neuronal TGF‐β signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Invest 2006; 116: 3060–9
   PubMed Web of Science ®Google Scholar